Formulation and evaluation of diclofenac potassium fast-disintegrating tablets and their clinical application in migraine patients

Drug Development and Industrial Pharmacy

Volumn 37, Issue 3, 2011, Pages 260-267

  Comoglu, Tansel ^a   Dogan, Aysegul ^b   Comoglu, Selcuk ^c   Basci, Nursabah ^b  

^a ANKARA UNIVERSITY   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c Diskapi Education and Research Hospital   (Turkey)

Author keywords

Di Pac ; diclofenac potassium; fast disintegrating tablets; migraine; Tablettose 70

Indexed keywords

DICLOFENAC POTASSIUM; FILLER; PLACEBO;

ADULT; ANALGESIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG DETERMINATION; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG STRUCTURE; FEMALE; HUMAN; IN VIVO STUDY; MALE; MIGRAINE; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SPECTROPHOTOMETRY; TABLET COMPRESSION; TABLET DISINTEGRATION TIME; TABLET FORMULATION; TABLET HARDNESS; TABLET POROSITY; TASTE;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CROSS-OVER STUDIES; DICLOFENAC; DOSAGE FORMS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; EXCIPIENTS; FEMALE; FLAVORING AGENTS; HARDNESS; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PLACEBOS; POROSITY; TABLETS; TASTE; YOUNG ADULT;

EID: 79952924311     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2010.505929     Document Type: Article

References (29)

1. Mishra DN, Bindal M, Singh SK, Kumar SGV. (2006). Spray dried excipient base: A novel technique for the formulation of orally disintegrating tablets. Chem Pharm Bull, 54(1):99-102. (Pubitemid 43036758)
2. Shu T, Suzuki H, Hironaka K, Ito K. (2002). Studies of rapidly dis-integrating tablets in the oral cavity using co-ground mixtures of mannitol with crospovidone. Chem Pharm Bull, 50(2):193-8. (Pubitemid 41694579)
3. Bogner RH, Wilkosz MF. Fast dissolving tablets. http://www. uspharmacist.com [accessed May 20, 2010].
4. Bolhuis GK, Rexwinkel EG, Zuurman K. (2009). Polyols as fillers-binders for disintegrating tablets prepared by direct compac-tion. Drug Dev Ind Pharm, 35(6):671-7.
5. Chang RK, Guo X, Couch RA. (2000). Fast dissolving tablets. Pharm.Technol, 6:52-8.
6. Seager H. (1998). Drug-delivery products and the Zydis fast-dissolving dosage form. J Pharm Pharmacol, 50:375-82. (Pubitemid 28197414)
7. Habib W, Khankari RK, Hontz J. (2000) Fast dissolve drug delivery systems. Crit Rev Ther Drug Carrier Sys, 17:61-72. (Pubitemid 30174149)
8. Jacob S, Shirwaikar A, Nair A. (2009). Preparation and evalua-tion of fast-disintegrating effervescent tablets of glibenclamide. Drug Dev Ind Pharm, 35(3):321-8.
9. Sunada H, Bi Y. (2002). Preparation, evaluation and optimization of rapidly disintegrating tablets. Powder Technol, 122:188-98. (Pubitemid 34041549)
10. Chang DJ, Desjardins PJ, Chen E, Polis AB, McAvoy M, Mockoviak SH, et al. (2002). Comparison of the analgesic efficacy of rofecoxib and enteric-coated diclofenac sodium in the treatment of postoperative dental pain: A randomized, placebo-controlled clinical trial. Clin Ther 24(4):490-503. (Pubitemid 34492872)
11. McNeely W, Goa KL. (1999). Diclofenac-potassium in migraine: A review. Drugs, 57(6):991-1003.
12. Diener HC, Montagna GG, Lyczak P, Schumann G, Zöller B, Mulder LJMM, et al. (2005). Efficacy and tolerability of diclofenac potassium sachets in migraine: a randomized, double-blind, cross-over study in comparison with diclofenac potassium tablets and placebo. Cephalalgia, 26:537-47. (Pubitemid 43601218)
13. Silberstein SD, Freitag FG. (2003). Preventive treatment of migraine. Neurology 60(7)Suppl.2:38-44.
14. Bucci R, Magrì AD, Magrì AL. (1998). Determination of diclofenac salts in pharmaceutical formulations. Fresenius J Anal Chem, 362:577-82. (Pubitemid 128692795)
15. ICH Guideline (1996). Validation of analytical procedures: Text and methodology Q2 (R1).
16. Bi YX, Sunada Y, Yonezawa Y, Danjo K. (1999). Evaluation of rapidly disintegrating tablets prepared by a direct compression method. Drug Dev Ind Pharm, 25(5):571-81. (Pubitemid 29186288)
17. Comoglu T, Gönül N. (2005). Quality control studies on conven-tional carbamazepine tablets that are available in Turkish drug market. Turk J Med Sci, 35:217-21. (Pubitemid 41248042)
18. Klancke J. (2003). Dissolution testing of orally disintegrating tablets. Dissolution Technologies, May: 6-8.
19. Kimura S, Imai T, Ueno M, Otagiri M. (1992). Pharmaceutical evaluation of ibuprofen fast absorbed syrup containing low-molecular weight gelatin. J Pharm Sci, 81:141-4.
20. Ishikawa T, Mukai B, Shiraishi S, Utoguchi N, Fujii M, Matsumoto M, et al. (2001). Preparation of rapidly disintegrating tablet using new types of microcrystalline cellulose (PH-M series) and low substituted- hydroxypropylcellulose or spherical sugar granules by direct compression method. Chem Pharm Bull, 49(2):134-9. (Pubitemid 32174644)
21. Kubitzek F, Ziegler G, Gold MS, Liu JMH, Ionescu E. (2003). Low-dose diclofenac potassium in the treatment of episodic tension-type headache. Eur J Pain, 7:155-62. (Pubitemid 36330533)
22. Bolhius GK, Chowhan ZT. (1996). Materials for direct compres-sion. In: Alderborn G, Nystrom C, eds. Pharmaceutical powder compaction technology. New York: Marcel Dekker Inc., 476-80.
23. Ilic I, Kasa JP, Dreu R, Hodi-Pintye K, Srcic S. (2009). The compressibility and compactibility of different types of lactose. Drug Dev Ind Pharm, 35(10):1271-80.
24. David ST, Augsberger LL. (1977). Plastic flow during compres-sion of directly compressible fillers and its effect on tablet strength. J Pharm Sci 66:155.
25. Gohel MC, Jogani PD. (2005). A review of co-processed directly compressible excipients. J Pharm Pharmaceut Sci, 8(1):76-93, www.cspscanada.org [accessed May 20, 2010]. (Pubitemid 41528873)
26. Rizzuto AB, Chen AC, Veign MF. (1984). Effect of moisture content on compression properties of two dextrose-based directly compressible diluents. Pharm Tech 8(9):32.
27. Shangraw R, Mitrejev A, Shah M. (1980). A new era of tablet disintegrants. Pharm Tech 4:49-57. (Pubitemid 11198249)
28. Mizumoto T, Yoshinori M, Yamamoto T, Yonemochi E, Terada K. (2005). Formulation design of a novel fast-disintegrating tablet. Int J Pharm 306: 83-90. (Pubitemid 41643142)
29. Webb PA. Volume and density determinations for particle technologists. Micromeritics Instrument Corp. 2001: p. 4. www. particletesting.com/docs/ density-determinations.pdf [accessed May 20, 2010]. en.wiktionary.org/wiki/true- density [accessed May 20, 2010].